Medtronic (MDT) closed at $83.62 in the latest trading session, marking a +0.55% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.58%. Meanwhile, the Dow gained ...

Shares of Medtronic PLC MDT advanced 1.02% to $83.16 Wednesday, on what proved to be an all-around positive trading session ...

Medtronic plc MDT is scheduled to report fourth-quarter and full-year fiscal 2025 results on May 21, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.39 ...

Shares of Medtronic PLC MDT slid 1.35% to $82.32 Tuesday, on what proved to be an all-around poor trading session for the ...

The medtech giant launched Medtronic Spark: a 10-year initiative designed to attract 1 million low-income students to careers in health tech.

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.

Looking ahead to fiscal year 2026, Medtronic plans to report its first, second, third, and fourth quarter results on Tuesday, August 19, 2025, November 18, 2025, February 17, 2026, and Wednesday, May ...

William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful ...

Medtronic has won Food and Drug Administration approval for the Omniasecure defibrillation lead, the company said Friday. The ...

A little over a month after announcing her departure from Moderna, Kate Cronin has begun her “next adventure.” Cronin has ...

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal AfibDual-energy ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...